No Improvement In Survival With Hormone Therapy For Prostate Cancer

An article published in the July 9 issue of JAMA finds that elderly men with localized prostate cancer had no improvement in survival when treated with a therapy that deprives the prostate gland of androgen (a male hormone) compared to conservative management of the disease. Among men, prostate cancer is the most common cancer after skin cancer and is the second leading cause of cancer deaths after lung cancer.

More: continued here

Filed under: Men's health on July 16th, 2008